X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hepatocellular carcinoma (5) 5
[ sdv ] life sciences [q-bio] (4) 4
dosimetry (4) 4
life sciences (4) 4
female (3) 3
humans (3) 3
index medicus (3) 3
liver (3) 3
radiation therapy (3) 3
radioembolization (3) 3
treatment outcome (3) 3
90y-microspheres (2) 2
aged, 80 and over (2) 2
antitubercular agents - therapeutic use (2) 2
cancer (2) 2
cancer therapies (2) 2
cardiomyopathies - diagnostic imaging (2) 2
cardiomyopathies - drug therapy (2) 2
cardiomyopathies - microbiology (2) 2
dosimeters (2) 2
fluorodeoxyglucose f18 (2) 2
heart - diagnostic imaging (2) 2
heart - microbiology (2) 2
histograms (2) 2
liver cancer (2) 2
oncology: liver (2) 2
positron-emission tomography (2) 2
predictive value of tests (2) 2
radiobiology/dosimetry (2) 2
radionuclide therapy (2) 2
radiopharmaceuticals (2) 2
single photon emission computed tomography (2) 2
therapy (2) 2
time factors (2) 2
tuberculoma - diagnostic imaging (2) 2
tuberculoma - drug therapy (2) 2
tuberculoma - microbiology (2) 2
tuberculosis, cardiovascular - diagnostic imaging (2) 2
tuberculosis, cardiovascular - drug therapy (2) 2
tuberculosis, cardiovascular - microbiology (2) 2
tumors (2) 2
yttrium isotopes (2) 2
[sdv.can]life sciences [q-bio]/cancer (1) 1
[sdv]life sciences [q-bio] (1) 1
administration, oral (1) 1
adult (1) 1
aged (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
brachytherapy - methods (1) 1
bsa (1) 1
carcinoma, hepatocellular - drug therapy (1) 1
carcinoma, hepatocellular - mortality (1) 1
carcinoma, hepatocellular - pathology (1) 1
carcinoma, hepatocellular - radiotherapy (1) 1
carcinoma, hepatocellular/drug therapy (1) 1
carcinoma, hepatocellular/radiotherapy (1) 1
clinical aspects (1) 1
clinical outcomes (1) 1
clinical trials (1) 1
comparative analysis (1) 1
competing risk (1) 1
convolution (1) 1
correlation analysis (1) 1
correlation coefficient (1) 1
correlation coefficients (1) 1
disease (1) 1
disease-free survival (1) 1
dose-response relationship, drug (1) 1
drug administration schedule (1) 1
drug dosages (1) 1
follow-up studies (1) 1
gastroenterology (1) 1
geriatrics & gerontology (1) 1
glass (1) 1
hepatic metastases (1) 1
hepatocellular-carcinoma (1) 1
hepatology (1) 1
hepatoma (1) 1
heterogeneity (1) 1
imaging (1) 1
in vivo methods and tests (1) 1
kaplan-meier estimate (1) 1
limitations (1) 1
liver neoplasms - drug therapy (1) 1
liver neoplasms - mortality (1) 1
liver neoplasms - pathology (1) 1
liver neoplasms - radiotherapy (1) 1
liver neoplasms/drug therapy (1) 1
lungs (1) 1
male (1) 1
mathematical analysis (1) 1
mathematical models (1) 1
medical instruments (1) 1
medical prognosis (1) 1
medical treatment (1) 1
mesh: carcinoma, hepatocellular/drug therapy (1) 1
mesh: carcinoma, hepatocellular/radiotherapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Vilgrain, Valérie and Pereira, Helena and Assenat, Eric and Guiu, Boris and Ilonca, Alina Diana and Ilonca, Alina D and Pageaux, Georges-Philippe and Sibert, Annie and Bouattour, Mohamed and Lebtahi, Rachida and Allaham, Wassim and Barraud, Hélène and Laurent, Valérie and Mathias, Elodie and Bronowicki, Jean-Pierre and Tasu, Jean-Pierre and Perdrisot, Rémy and Silvain, Christine and Gerolami, René and Mundler, Olivier and Seitz, Jean-Francois and Vidal, Vincent and Aubé, Christophe and Oberti, Frédéric and Couturier, Olivier and Brenot-Rossi, Isabelle and Raoul, Jean-Luc and Sarran, Anthony and Costentin, Charlotte and Itti, Emmanuel and Luciani, Alain and Adam, René and Lewin, Maïté and Samuel, Didier and Ronot, Maxime and Dinut, Aurelia and Castera, Laurent and Chatellier, Gilles and Delhom - Christol, Elisabeth and Lonjon, Julie and Abdel-Rehim, Mohamed and Dieudonné, Arnaud and Bazin, Christophe and Chagneau-Derrode, Carine and Borentain, Patrick and Bouvier, Antoine and Vervueren, Laurent and Chalaye, Julia and Kobeiter, Hicham and Edeline, Julien and Garin, Etienne and Rolland, Yan and Archambeaud, Isabelle and Eugene, Thomas and Frampas, Eric and Cassinotto, Christophe and Guyot, Martine and Hiriart, Jean-Baptiste and Lapuyade, Bruno and Vergniol, Julien and Bachellier, Philippe and Detour, Julien and Duclos, Bernard and Greget, Michel and Habersetzer, Francois and Imperiale, Alessio and Merle, Philippe and Rode, Agnès and Morvan, Julie and Nguyen-Khac, Eric and Yzet, Thierry and Baudin, Guillaume and Chevallier, Patrick and Mahamat, Abakar and Piche, Thierry and Razzouk, Micheline and Hillon, Patrick and Loffroy, Romaric and Toubeau, Michel and Vincent, Julie and Barabino, Gabriele and Bouarioua, Nadia and Cuilleron, Muriel and Ecochard, Marie and Prevot-Bitot, Nathalie and Leroy, Vincent and Roux, Julie and Sengel, Christian and Bourcier, Valérie and Ganne-Carrie, Nathalie and Seror, Olivier and Costo, Sylvie and Dao, Thông and Pelage, Jean-Pierre and Dumortier, Jérôme and Giammarile, Francesco and Valette, Pierre-Jean and Ghazzar, Nadia and Pellerin, Olivier and Taieb, Julien and ... and SARAH Trial Grp and SARAH Trial Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1624 - 1636
Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of... 
SURVIVAL | THERAPY | ONCOLOGY | COMPETING RISK | TRANSARTERIAL CHEMOEMBOLIZATION | RADIOEMBOLIZATION | QUALITY-OF-LIFE | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Microspheres | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Neoplasm Invasiveness - pathology | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Yttrium Radioisotopes - therapeutic use | Radiotherapy Dosage | Drug Administration Schedule | Administration, Oral | Brachytherapy - methods | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Carcinoma, Hepatocellular - radiotherapy | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Liver Neoplasms - radiotherapy | Sorafenib | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Neoplasm Staging | Rare earth metals | Antimitotic agents | Product development | Hepatoma | Comparative analysis | Radiotherapy | Antineoplastic agents | Life Sciences | Liver Neoplasms/drug therapy | Phenylurea Compounds/administration & dosage | Yttrium Radioisotopes/therapeutic use | Niacinamide/analogs & derivatives | Carcinoma, Hepatocellular/radiotherapy | Carcinoma, Hepatocellular/drug therapy | Cancer
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 08/2018, Volume 59, Issue 8, p. 1289
The aim of this study was to quantitatively evaluate the ability of the body-surface-area (BSA) model to predict tumor-absorbed dose and treatment outcome... 
Dosimeters | Medical treatment | Liver | Hepatocellular carcinoma | Radiation therapy | Single photon emission computed tomography | Clinical outcomes | Yttrium isotopes | Heterogeneity | Histograms | Lungs | Mathematical models | Dosimetry | Drug dosages | Tumors
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 03/2018, Volume 59, Issue 8, pp. 1289 - 1295
The aim of this study was to quantitatively evaluate the body surface area (BSA) model ability to predict tumor absorbed dose and treatment outcome through... 
Life Sciences
Journal Article
Age and ageing, ISSN 0002-0729, 01/2015, Volume 44, Issue 1, pp. 173 - 174
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.